BioSpace News Archive

Algernon Pharmaceuticals Inc. is pleased to announce that it has recently received a CAD$2M cash payment from a refundable tax credit program from its clinical research work in Australia, which brings Algernon’s current working capital balance to approximately CAD$3.5M.

ProMIS Neurosciences Inc. is pleased to announce that, further to its news release of October 7, 2021, it is filing today on SEDAR the management information circular for the special general meeting of shareholders (the “Special Meeting”) to be held on December 1, 2021.

CareDx, Inc. today congratulated OrganX on the completion of a landmark longitudinal study that shows AlloSure is more accurate than current standards of care

Synthetic Biologics, Inc. today announced that enrollment has commenced and eight study participants were dosed in the Company’s Phase 1, placebo-controlled, multiple-ascending dose (MAD) clinical study of SYN-020 intestinal alkaline phosphatase (IAP).

908 Devices Inc. today announced it will report financial results for the third quarter 2021 before market open on Thursday, November 4, 2021.

ITOCO INC. (OTC PINK:ITMC) is pleased to welcome Maria Teresa Tattersfield Yarza to its Board of Directors.

Small Pharma Inc. is pleased to announce that following discussions with the U.K. Medicines and Healthcare products Regulatory Agency (the “ MHRA ”), Small Pharma has been granted an Innovation Passport Designation for SPL026

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021.

Calithera Biosciences, Inc. today announced that data from its Phase 1b trial of CB-280, the company’s investigational arginase inhibitor for the treatment of cystic fibrosis (CF), will be shared in a poster presentation at the North American Cystic Fibrosis Conference (NACFC), taking place virtually November 2-5, 2021.

Phathom Pharmaceuticals, Inc. will be presented at the ACG 2021 Annual Scientific Meeting in Las Vegas, Nevada, organized by the American College of Gastroenterology, October 22-27.